Durham, NC, United States of America

Stephen Carraway


Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2023

where 'Filed Patents' based on already Granted Patents

4 patents (USPTO):

Title: Innovations in Clinical Trials: The Contributions of Stephen Carraway

Introduction

Stephen Carraway, an innovative inventor based in Durham, NC, has made significant strides in the field of clinical trial evaluation through his groundbreaking patents. With a total of four patents to his name, Carraway leverages machine learning technology to enhance the quality and success of clinical trials.

Latest Patents

Carraway's latest patents include methods and computing platforms designed to evaluate data quality during clinical trials based on participant queries. One of his notable inventions provides a system that receives study design information and utilizes this data alongside queries from trial participants to predict a data quality score, ultimately leading to suggestions for improvement. Another of his key patents focuses on using machine learning to design and implement clinical trials that maximize the likelihood of success. This invention predicts multiple success scores based on varying parameter values, helping researchers define optimal conditions for successful outcomes.

Career Highlights

Stephen Carraway's professional journey has seen him associated with prominent companies such as Merative, which is known for its innovative health technology solutions, and Salesforce, Inc., a leader in cloud-based customer relationship management. His work in these organizations has empowered enhanced strategies in clinical research and data analysis.

Collaborations

Throughout his career, Carraway has collaborated with talented professionals including Adrian Vrouwenvelder and Kimberly Diane Kenna. These partnerships have contributed to the development and refinement of his patents, bringing together a wealth of expertise in clinical trials and technology.

Conclusion

Stephen Carraway's contributions to the field of clinical trials through his patents reflect a commitment to innovation and improving healthcare outcomes. By harnessing machine learning to assess and enhance data quality, he is paving the way for more reliable and successful clinical research methodologies. His ongoing work and collaborations continue to drive advancements in this critical area of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…